NCT00022906View on ClinicalTrials.gov

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 1999

Conditions
Non-Hodgkin's Lymphoma
Interventions
DRUG

Iodine-131 Anti-B1 Antibody

Trial Locations (1)

10021

Cornell Medical Center, New York

Sponsors

Lead Sponsor

Corixa Corporation

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Corixa Corporation

INDUSTRY